Participated · Series A · Mar 2022

Colossal Biosciences focuses on applying AI to biological questions, including predicting how biological systems fail or break. The company is co-founded by Ben Lamm and has been associated publicly with figures such as George Church, Beth Shapiro, and Adam Milne. Financially, Colossal announced a $20 million financing at a $3.8 billion valuation. The recent capital raise is described as supporting its AI initiatives. The provided articles do not include revenue, user, or other operating metrics, nor do they state the company's founding year or location.